The Food and Drug Administration (FDA) on Monday launched a new initiative to speed up early-stage clinical trials as part of an effort to reduce development timelines and reverse a growing trend of ...
The Chosun Ilbo on MSN
US Congress investigates Chinese clinical trials tied to military capabilities
The U.S. Congress has launched an investigation into the possibility that clinical trials conducted by global pharmaceutical ...
WASHINGTON — Clinical trial policy got caught up in the Trump administration’s attack on policies related to diversity, ...
By Deena Beasley June 30 (Reuters) - The chair of the U.S. House Select Committee on China opened national security ...
The Trump administration is launching a new effort to bolster domestic clinical trials for new pharmaceutical products after a year of tumult at the federal health agencies that has slowed down new ...
The US Department of Health and Human Services on Monday announced a cross-agency effort to speed up regulatory checkpoints ...
On June 22, 2026, the U.S. Department of Health and Human Services (HHS) announced the launch of Operation TrialBlazer, a coordinated effort ...
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...
While the US and China command the race to the top, up-and-coming players like Spain could offer the UK some pointers as it ...
Two innovative, forward-thinking organizations show how rebuilding patient trust is becoming the real breakthrough driving ...
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results